• Media type: E-Article
  • Title: Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
  • Contributor: Moretto, Roberto; Elliott, Andrew; Rossini, Daniele; Intini, Rossana; Conca, Veronica; Pietrantonio, Filippo; Sartore-Bianchi, Andrea; Antoniotti, Carlotta; Rasola, Cosimo; Scartozzi, Mario; Salati, Massimiliano; Pella, Nicoletta; Calegari, Maria Alessandra; Carullo, Martina; Corti, Francesca; Mauri, Gianluca; Fassan, Matteo; Masi, Gianluca; Brodskiy, Pavel; Lenz, Heinz-Josef; Shields, Anthony; Lonardi, Sara; Korn, Michael; Cremolini, Chiara
  • Published: Springer Science and Business Media LLC, 2022
  • Published in: British Journal of Cancer, 127 (2022) 5, Seite 957-967
  • Language: English
  • DOI: 10.1038/s41416-022-01852-0
  • ISSN: 0007-0920; 1532-1827
  • Origination:
  • Footnote:
  • Access State: Open Access